201/283US=35 / Biol/Mol
Sato M, Shames DS, Girard L, Gazdar AF, Minna JD. Molecular basis of lung cancer. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 397-407. ISBN 978-1-4160-3703-3.

CANCER DE PULMAO; BIOLOGIA MOLECULAR; INSTABILIDADE GENOMICA


202/283US=23-A / Câncer
Gwyther SJ. Detection of recurrent cancer by radiological imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 17-37. ISBN 978-1-4020-8441-62.

CANCER. DIAGNOSTICO; IMAGEM; RADIOLOGIA; CANCER DE PULMAO; CANCER DE MAMA; CANCER COLORRETAL; LINFOMA; CANCER PANCREATICO; CANCER DE PROSTATA; CANCER DE ESOFAGO; CANCER DE OVARIO; CANCER DE ENDOMETRIO; CANCER CERVICAL; CANCER DE CABECA E PESCOCO; CANCER DE TIREOIDE; TUMORES INTRACRANIANOS PRIMARIO


203/283US=2 / Tórax
Dartevelle PG, Yildizeli B, Mussot S. Extended resections for lung cancer. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 194-220. ISBN 978-1-4051-5112-2.

RESSECCAO EXTENDIDA PARA CANCER DE PULMAO; CANCER DE PULMAO; INVASAO DA PAREDE TORACICA; RESSECCAO CARINAL


204/283US=2 / Tórax
Tsao AS. New chemotherapeutic agents in lung cancer. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 315-333. ISBN 978-1-4051-5112-2.

AGENTES QUIMIOTERAPICOS NO CANCER DE PULMAO; CANCER DE PULMAO


205/283US=23-A / Câncer
Das M. Small pulmonary nodules: detection using multidetector-row computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 247-60. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; NODULOS PULMONARES; TOMOGRAFIA COMPUTADORIZADA; GRANULOMA; HARMATOMA; METASTASE


206/283US=23-A / Câncer
Takigawa N, Segawa Y, Kiura K. Secondary primary cancer following chemoradiation for non-small-cell lung cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 261-7. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; QUIMIORRADIACAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS


207/283US=23-A / Câncer
Gridelli C, Maione P. Advanced non-small cell lung cancer: second-line treatment with docetaxel. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 269-80. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; DOCETAXEL; TRATAMENTO


208/283US=23-A / Câncer
Nelli F, Moscetti L. Non-small cell lung cancer with brain metastases: platinum-based chemotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 281-9. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; METASTASES CEREBRAIS; QUIMIOTERAPIA; PLATINA


209/283US=23-A / Câncer
Bartolazzi A. Non-small cell lung carcinoma: EGFR gene mutations and response to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 291-306. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; MUTACOES EGFR; GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO


210/283US=23-A / Câncer
Kiura K, Takigawa N, Segawa Y. Advanced non-small cell lung carcinoma: acquired resistance to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 307-16. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; CARCINOMA NAO PEQUENAS CELULAS DO PULMAO AVANCADA; RESISTENCIA A GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO


211/283US=23-A / Câncer
Nomori H. Prognostic significance of [18F]-Fluorodeoxyglucose uptake on positron emission tomography in patients with pathological stage I lung adenocarcinoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 317-22. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; PROGNOSTICO; [18F]-FLUORODEOXIGLICOSE; TOMOGRAFIA POR EMISSAO DE POSITRONS; ESTADIO PATOLOGICO I; ADENOCARCINOMA DE PULMAO


212/283US=23-A / Câncer
Pfannschmidt J, Bulzebruck H, Dienemann H. Non-small cell lung cancer: prognosis using the TNM staging system. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 323-36. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; PROGNOSTICO; SISTEMA TNM; CLASSIFICACAO DE TUMORES MALIGNOS


213/283US=23-A / Câncer
Benlloch S, Galbis-Caravajal JM, Massutí B. Differentiation between malignant and benign pleural effusions: methylation specific polymerase chain reaction analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 337-47. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; DERRAME PLEURAL MALIGNO; DERRAME PLEURAL BENIGNO; METILACAO; POLIMERASE; REACAO EM CADEIA


214/283US=23-A / Câncer
Hiroshima K. Pathological distinction of pulmonary large cell neuroendocrine carcinoma from small-cell lung carcinoma using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 349-61. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CARCINOMA PULMONAR DE CELULAS GRANDES; CARCINOMA DE PULMAO DE PEQUENAS CELULAS; IMUNOHISTOQUIMICA; CARCINOMA DE GRANDES CELULAS NEUROENDOCRINO; MORFOMETRIA; BIOLOGIA MOLECULAR


215/283US=23-A / Câncer
Zander DS, Clarke LE. Differentiation between pleuropulmonary desmoid tumors and solitary fibrous tumors: role of histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 363-9. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; TUMORES PLEUROPULMONARES DESMOIDE; TUMORES FIBROSOS SOLITARIOS; HISTOLOGIA; IMUNOHISTOQUIMICA; PATOLOGIA MACROSCOPICA; PATOLOGIA MICROSCOPICA


216/283US=23-A / Câncer
Ma ESK, Wong CLP. Non-small cell lung cancer with brain metastasis: role of epidermal growth factor receptor gene mutation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 371-87. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; METASTASE CEREBRAL; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; MUTACAO DO GENE


217/283US=2 / Tórax
Sharafkhaneh A, Velamuri S, Moghaddam SJ, Badmaev V, Dickey B, Kurie J. Natural agents for chemoprevention of lung cancer. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 441-55. ISBN 978-1-4051-5112-2.

QUIMIOPREVENCAO DO CANCER DE PULMAO; CANCER DE PULMAO


218/283US=29 / Imagem
Steinert HC. Lung cancer. In: Dresel S, editor. Pet in oncology. New York: Springer- Verlag, 2008. p. 81-92. ISBN 978-3-540-31202-4.

CANCER DE PULMAO; NAO-PEQUENAS DE CANCER DE PULMAO DE CELULAS; NODULO PULMONAR SOLITARIO; PET E INTEGRADA PET / CT; ENCENACAO LINFONODOS MEDIASTINAIS; MONITORAMENTO DE TERAPIA; CANCER DE PULMAO RECORRENTE; CANCER DE PULMAO DE PEQUENAS CELULAS; MESOTELIOMA MALIGNO DA PLEURA


219/283US=29 / Imagem
Palmedo H, Gróhe C, Tasci S. PET and PET/CT with F-18 fluoride in bone metastases. In: Dresel S, editor. Pet in oncology. New York: Springer- Verlag, 2008. p. 213-24. ISBN 978-3-540-31202-4.

PET; PET / CT COM F-18 DE FLUOR EM METASTASES OSSEAS; CANCER DE PULMAO; CANCER DE PROSTATA; CANCER DE MAMA


220/283US=30-A / Câncer
Subramanian J, Govindan R. Lung cancer. In: Govindan R. The Washington manual of oncology. 2 nd. Philadelphia: J.B. Lippincott, 2008. p. 134-48. ISBN 978-1-5889-0323-0.

CANCER DE PULMAO


Primeira | Anterior | Próxima | Última